Transport of a new erectogenic udenafil in Caco-2 cells

Archives of Pharmacal Research

Volumn 30, Issue 9, 2007, Pages 1168-1173

  Hye, Young Ji ^a   Hyun, Joo Shim ^b   Yoo, Moohi ^b   Park, Eun Seok ^c   Hye, Suk Lee ^a  

^a Wonkwang University   (South Korea)

^b Dong A Pharmaceutical Company   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Caco 2; P glycoprotein; Transport; Udenafil

Indexed keywords

EID: 34948831522     PISSN: 02536269     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf02980254     Document Type: Article

References (25)

1. Ambudkar, S. V., Dey, S., Hrycyna, C. A., Ramachandra, M., Pastan, I., and Gottesman, M. M., Biochemical, cellular and pharmacological aspects of the multidrug transporter. Ann. Rev. Pharmacol. Toxicol., 39, 361-398 (1999).
2. Ahn, B. O., Kang, K. K., Ahn, G. J., Kwon, J. W., Kim, W. B., Kang, K. S., and Lee, Y. S., Efficacy of DA-8159, a new PDE5 inhibitor, for inducing penile erection in rabbits with acute spinal cord injury. Int. J. Impot. Res., 15, 405-411 (2003).
3. Benet, L. Z. and Cummins, C. L., The drug efflux-metabolism alliance: biochemical aspects. Adv. Drug Del. Rev., 50, S3-S11 (2001).
4. Choi, S. J., Ji, H. Y., Lee, H. Y., Kim, D. S., Kim, W. B., and Lee, H. S., In vitro metabolism of a novel phosphodiesterase-5 inhibitor DA-8159 in rat liver preparations using liquid chromatography/electrospray mass spectrometry. Biomed. Chromatogr., 16, 395-399 (2002).
5. Drueckes, P., Schinzel, R., and Palm, D., Photometric microtiter assay of inorganic phosphate in the presence of acid-labile organic phosphates. Anal. Biochem., 230, 173-177 (1995).
6. Gan, L. L., Moseley, M. A., Khosla, B., Augustijns, P. F., Bradshaw, T. P., Hendren, R. W., and Thakker, D. R., CYP3A-like cytochrome P450-mediated metabolism and polarized efflux of cyclosporin A in Caco-2 cells: Interaction between the two biochemical barriers to intestinal transport. Drug Metab. Dispos., 24, 344-349 (1996).
7. Gres, M. C., Julian, B., Bourrie, M., Meunier, V., Roques, C., Berger, M., Boulenc, X., Berger, Y., and Fabre, G., Correlation between oral drug absorption in humans, and apparent drug permeability in TC-7 cells, a human epithelial intestinal cell line: comparison with the parental Caco-2 cell line. Pharm. Res., 15, 726-733 (1998).
8. Hidalgo, I. J., Assessing the absorption of new pharmaceuticals. Current Topics Med. Chem., 1, 385-401 (2001).
9. Hoffmeyer, S., Burk, O., Von Richter, O., Arnold, H. P., Brockmoller, J., Johne, A., Cascorli, I., Gerloff, T., Roots, I., Eichelbaume, M., and Brinkmann, U., Functional polymorphism of the human multidrug-resistant gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc. Natl. Acad. Sci., 97, 4373-4378 (2000).
10. Hunter, J., Hirst, B. H., and Simmons, N. L., Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res., 10, 743-749 (1993).
11. Ji, H. Y., Lee, H. W., Kim, H. H., Kim, D. S., Yoo, M., Kim, W. B., and Lee, H. S., Role of human Cytochrome P450 3A4 in the metabolism of DA-8159, a new erectogenic. Xenobiotica, 34, 973-982 (2004).
12. Kang, K. K., Yu, J. Y., Yoo, M., and Kwon, J. W., The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction. Int. J. Impot. Res., 17, 409-416 (2005).
13. Kim, J., Kim, S. J., Ji, H. Y., Jin, J. K., Lee, S. S., Kim, D. S., Yoo, M., Kim, W. B., and Lee, H. S., Simultaneous determination of a new phosphodiesterase-5 inhibitor DA-8159 and its active metabolite in human plasma by high performance liquid chromatography with tandem mass spectrometry. Chromatographia, 57, 447-450 (2003).
14. Kim, H. H., Ji, H. Y., Lee, H. Y., Kim S. A., Lee, S., Yi, K. Y., and Lee, H. S., Characterization of cytochrome P450 enzymes and P-glycoprotein involved in the metabolism and transport of a new anti-angiogenic agent KR-31831. Drug Devel. Res., 66, 40-49 (2006).
15. Martin, C., Berridge, G., Mistry, P., Higgins, C., Charlton, P., and Callaghan, R., The molecular interaction of the affinity reversal agent XR9576 with P-glycoprotein. Br. J. Pharmacol., 128, 403-411 (1999).
16. Meunier, V., Bourrié, M., Berger, Y., and Fabre, G., The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic applications. Cell. Biol. Toxicol., 11, 187-194 (1995).
17. Oh, T. Y., Kang, K. K., Ahn, B. O., Yoo, M., and Kim, W. B., Erectogenic effect of the selective phosphodiesterase type 5 inhibitor, DA-8159. Arch. Pharm. Res., 23, 471-476 (2000).
18. Sarkardi, B, Price, E. M., Boucher, R. C., Germann, U. A., and Scarborough, G. A., Expression of the human multidrug resistance cDNA in insect cells generates a high-activity drug-stimulated membrane ATPase. J. Biol. Chem., 267, 4854-4858 (1992).
19. 3. Mol. Pharmacol., 51, 741-754 (1997).
20. Shim, H. J., Kim, Y. C., Park, K. J., Kim, D. S., Kwon, J. W., Kim, W. B., and Lee, M. G., Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. J. Pharm. Sci., 2185-2195 (2003).
21. Silverman, J. A., P-Glycoprotein. In: Levi, R. H., Thummel, K. E., Trager, W. F., Hansten, P. D., Eichelbaum, M., editors. Metabolic Drug Interactions. Philadelpia, Lippincott Williams & Wilkins. p 135-144 (2000).
22. Wacher, V. J., Wu, C. Y., and Benet, L. Z., Overlapping substrate specificities and tissue distribution of cytochrme P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy. Mol. Carcinog., 13, 129-134 (1995).
23. Wacher, V. J., Salphati, L., and Benet, L. Z., Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv. Drug Deliv. Rev., 46, 89-102 (2001).
24. Walle, U. K. and Walle, T., Taxol transport by human intestinal epithelial Caco-2 cells. Drug Metab. Dispos., 26, 343-346 (1998).
25. Williams, W. C. and Sinko, P. J., Oral absorption of the HIV protease inhibitors: a current update. Adv. Drug Deliv. Rev., 39, 211-238 (1999).